NIH-funded research U01 cooperative agreement

How dying cells influence the spread of breast cancer

Official title: Promotion of metastasis by apoptotic cells

Funded at University of Washington · NIH-11082372 · Data updated 2026-11-12

This study is looking at how dying cells might help breast cancer spread to other parts of the body, especially the lungs, and it aims to find new ways to stop that from happening.

More Metastasis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$699,332
NIH project number5U01CA289564-02
Project IDNIH-11082372 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with breast cancer, particularly those at risk of metastasis.

Less likely to help

Patients with non-breast cancer types or those whose cancer has already metastasized extensively may not benefit from this research.

What this research studies

This research investigates how apoptotic (dying) cells can promote the spread of breast cancer to other parts of the body. It explores the mechanisms by which these dying cells attract platelets and immune cells, potentially aiding cancer cells in surviving and establishing new tumors. The study will involve laboratory models to observe the interactions between apoptotic cells and cancer cells, focusing on their behavior in the lungs where metastasis often occurs. By understanding these processes, the research aims to identify new therapeutic targets to inhibit cancer spread.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing the metastasis of breast cancer, improving patient outcomes.

How similar studies have gone: Previous research has shown that targeting apoptotic cell interactions can influence cancer progression, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Oberst, Andrew Atwell — University of Washington
  • Study coordinator: Oberst, Andrew Atwell

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.